BTGIN Signed a contract to supply Rg3 products to Danang Oncology Hospital in Vietnam
Recently, BTGIN, the enzyme red ginseng specialized company, signed a supply contract with Danang Oncology Hospital in Vietnam to supply supplements (Royal G3 300, Rg3 HSC) enhanced by red ginseng’s specific ginsenoside Rg3.
These products were officially launched in Vietnam earlier this year after completing VFA certifications by the Vietnamese Ministry of Food and Drug Safety as health functional foods. These supplements mainly contain novel ginsenoside Rg3, which is well known for its anticancer function reports in the world.
For reference, BTGIN is a professional health functional food manufacturer that holds a patent for a ginsenoside formulation for lung cancer treatment, and the patent is closely related to specific ginsenoside Rg3.
In addition, according to worldwide clinical study reports, ginsenoside Rg3 shows cancer cell apoptosis, cancer cell growth inhibition, metastasis inhibition, etc. through experimental research results, including prostate cancer, breast cancer, ovarian cancer, rectal cancer, stomach cancer, and liver cancer. It was also explained that it showed angiogenesis inhibitory effect in lung cancer, etc.
Danang Oncology Hospital provides the above products for patients who want supplements while undergoing radio or chemotherapy.
Vietnam has 68,000 cancer patients in 2000, 126,000 in 2010, and 165,000 in 2018, with a cancer rate of 159.7 per 100,000 population, ranking 16th in Asia and 6th in Southeast Asia.
With this contract of BTGIN with Danang Oncology Hospital in Vietnam, it’s looked forward to help for many patients in Vietnam.
Premium Korean Red Ginseng
High Ginsenosides = Immune Support for Men & Women
Amazon Brand Shop:
#cancerpatients #cancerpatientsupplement #functionalhealthfood #ginseng #amazonginseng #redginseng #btgin #koreanredginseng #bestsupplement #saponin #naturalenergyboost

Scroll to Top